Navigation Links
Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th
Date:10/8/2008

PRINCETON, N.J., Oct. 8 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) management will present at the Natixis Bleichroeder Hidden Gems Conference being held from October 13-14, 2008 at the Waldorf Astoria in New York City. Michelle Berrey, Pharmasset's Chief Medical Officer, will provide an overview of the company on Monday, October 13, 2008, at 11:30 AM (ET).

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, for the treatment of chronic HBV infection, is enrolling Phase 3 clinical trials for registration in North, Central and South America and Europe. Clevudine is already approved for HBV in South Korea and marketed by Bukwang Pharmaceuticals in South Korea under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, is in a 4-week Phase 1 clinical trial in combination with Pegasys(R) plus Copegus(R) through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Contact

Richard E.T. Smith

Vice President of Investor Relations

richard.smith@pharmasset.com

Office: +1 (609) 613-4181


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
2. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
3. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
4. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
5. Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
6. Pharmasset Joins Russell 3000 Index
7. Pharmasset to Present at the Needham & Co. Biotechnology and Medical Technology Conference on Wednesday, June 11th
8. Pharmasset Selected to Join the NASDAQ Biotechnology Index
9. Pharmasset to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, April 30th
10. Pharmasset Adds Two Cohorts to R7128 Hepatitis C Study
11. Pharmasset to Present at the Canaccord Adams Hepatitis C Conference on Wednesday, April 9th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 30, 2014 The evening of ... decades-long heritage in successful medical device development to ... what it takes to successfully innovate in the ... of a two-hour on-site class, Insight gave master’s ... business, McCormick School of Engineering, medical and law ...
(Date:10/31/2014)... October 31, 2014 The report ... Rice), Formulation (Plain, Flavored, Sweetened, Unsweetened), Channel (Supermarket, ... Global Trends & Forecast to 2018," defines and ... analysis and forecast of revenue and volume for ... is projected to reach $14 Billion by 2018 ...
(Date:10/31/2014)... Oct. 31, 2014  Atlanta-based Intellimedix could make ... the onset of Ebola by suggesting a new, ... Georgia Tech,s Center for Computational Systems Biology have ... find alternative uses for existing drugs through systematic ... aid the bout against Ebola. ...
(Date:10/30/2014)... 30, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Naltrexone HCL information, including its definition, classification, application, ... overview. This research covers the international market analysis, ... industry analysis covering macroeconomic environment & economic situation ...
Breaking Biology Technology:Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3
... National Business Group on Health Names Leading Companies that Promote a ... ... The National Business,Group on Health (NBGH), a national non-profit organization of ... and promoting a healthy lifestyle for employees and their,families., GSK ...
... with Improved Usability & ... ... high incidence,of women,s health conditions that require intra-vaginal drug delivery and,the ... an alarming majority of women find their current treatment,options "unacceptable" or ...
... Germany, May 13 Caviar has become one ... view of the over fished,sturgeon populations in the ... sustainable aquaculture. United Food Technologies AG (UFT) has ... know-how in this sector.,This week, the company delivered ...
Cached Biology Technology:GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles 2GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles 3GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles 472% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds 2Sturgeon and Caviar From Aquaculture: United Food Technologies AG Hands Over Turnkey Plant 2
(Date:10/29/2014)... air pollutants released by unconventional oil and gas production ... published today in the open access journal Environmental ... formaldehyde were found. The study is the first to ... near production sites and could be used to supplement ... come from reserves that do not readily flow to ...
(Date:10/29/2014)... largest study of its kind to date, researchers have ... heighten the risk for autism. Joseph Buxbaum, Ph.D., Icahn ... Mark Daly, Ph.D., Broad Institute of Harvard and MIT, ... from affected children, parents and unrelated people. They identified ... to the risk for autism spectrum disorder (ASD) – ...
(Date:10/29/2014)... open for the Society of Interventional Radiology,s ... is the one place where interventional radiologists, ... care professionals can come together to find ... being presented, discussed and tested. , ... image-guided medicine, SIR 2015 will feature essential ...
Breaking Biology News(10 mins):Air quality and unconventional oil and gas sites 2Air quality and unconventional oil and gas sites 3SIR 2015: Interventional radiology shapes tomorrow's medicine 2
... the time, the immune system is the body,s protector, warding ... infection and disease. But in autoimmune diseases, the immune ... attacking normal cells. A major discovery by La Jolla ... previously unknown molecular interaction that is essential for T lymphocyte ...
... team of Russian veterinary colleagues and health experts from the ... distemper -- a virus afflicting domestic dogs and many wildlife ... tigers. The team presented its results at the first-ever ... Russian Far East city of Ussurisk. The symposium underscores ...
... stem cell therapies will be among the research topics ... on Cardiovascular Regenerative Medicine, which will be held Oct. ... into the state of the regenerative medicine field. ... Lung, and Blood Institute and the Foundation for the ...
Cached Biology News:La Jolla Institute discovers previously unknown cell interaction key in immune system attacks 2La Jolla Institute discovers previously unknown cell interaction key in immune system attacks 3Russian and US veterinarians collaborate to solve mysterious wild tiger deaths 2Russian and US veterinarians collaborate to solve mysterious wild tiger deaths 3NIH hosts Cardiovascular Regenerative Medicine Symposium Oct. 4-5 2
... GeneMaths XT is undoubtedly the most complete ... advanced concept of layers and subsets makes ... layers for different data outputs, for example ... etc., as well as different subsets of ...
...
...
... several important steps of angiogenesis including proliferation, migration, ... reduces intracellular reactive oxygen species (ROS) level, H(2)O(2)-dependent ... Formula: ... MolWeight: 360.31484 Store ...
Biology Products: